Novartis retools breast cancer site

Share this article:

Novartis relaunched its advancedbreastcancercommunity.org with a focus on an often sidelined patient population—the breast cancer patients who have to live as cancer patients, not necessarily as survivors.

Patient advocate Musa Mayer of advancedbc.org told MM&M the site uniquely focuses on patients who are unintentionally made “to feel like failures” amid a “relentless focus on celebration of survivorship.”

Ginny Knackmuhs, a board member of the all-volunteer Metastatic Breast Cancer Network said the site, which includes videos, resources and an online community, puts information about living with advanced breast cancer in one place, where patients with the disease can find it, and provides an opportunity to “get people thinking that metastatic patients are part of the larger story of breast cancer.”

The website, which includes links to patient videos, news and resources, initially launched with financial support from Bristol-Myers Squibb. The latest iteration includes links to news, resources, tools and an online community.

It also includes a link to Novartis' “Count Us, Know Us, Join Us” initiative that tries to show how many people are affected by advanced breast cancer—visitors help create a name mosaic if they are, or know, a person with advanced breast cancer.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?